Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.
Gyala Therapeutics's investors include Invivo Capital Partners, CDTI Innovación's INNVIERTE program, Nara Capital, Ministry of Science and Innovation of Spain.
Gyala Therapeutics is headquartered in Barcelona, Spain.
Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.
Gyala Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gyala Therapeutics — Funding & Investors." VCBacked, February 10, 2026, https://www.vcbacked.co/company/gyala-therapeutics. Accessed October 30, 2026.
VCBacked. (2026). Gyala Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/gyala-therapeutics
{{cite web |title=Gyala Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gyala-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated